↓ Skip to main content

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study

Overview of attention for article published in Frontiers in Pharmacology, October 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
Published in
Frontiers in Pharmacology, October 2023
DOI 10.3389/fphar.2023.1274692
Pubmed ID
Authors

Lenka N. C. Boyd, Lynn E. Nooijen, Mahsoem Ali, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 100%
Readers by discipline Count As %
Social Sciences 1 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2023.
All research outputs
#19,386,653
of 24,690,130 outputs
Outputs from Frontiers in Pharmacology
#8,099
of 18,744 outputs
Outputs of similar age
#118,624
of 186,349 outputs
Outputs of similar age from Frontiers in Pharmacology
#59
of 394 outputs
Altmetric has tracked 24,690,130 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,744 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,349 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 394 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.